Gadolinium DTPA Enhanced MR Imaging of ACTH-Secreting Microadenomas of the Pituitary Gland
- 1 September 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 12 (5) , 728-735
- https://doi.org/10.1097/00004728-198809010-00002
Abstract
Gadolinium diethylenetriamine pentaacetic acid (DTPA) enhanced magnetic resonance imaging was performed in eight patients with Cushing disease and surgically proven pituitary microadenomas. A 1.5 T scanner was used with 3 mm contiguous slices. Short repetition times (TR), short echo times (TE), and long TR, long TE sequences were obtained before and serially after intravenous administration of Gd-DTPA. Three of eight (38%) microadenomas were undetectable both without and with Gd-DTPA: one post-Gd-DTPA scan was false positive on the side opposite the adenoma. Hemihypophysectomy based on a petrosal sinus adrenocorticotropic hormone (ACTH) gradient cured all three patients. Two microadenomas (25%) were visible as hypointense foci following Gd-DTPA but not on unenhanced scans. The remaining three microadenomas (38%) were seen before and after Gd-DTPA on T1-weighted images. In this small series of ACTH-producing microadenomas, one-third were seen on unenhanced 1.5 T scans, one-third were seen only after Gd-DTPA, and one-third were not imaged even with Gd-DTPA enhancement.This publication has 3 references indexed in Scilit:
- MR IMAGING OF PROLACTIN-SECRETING MICROADENOMAS1986
- Clinical Applications of Corticotropin-Releasing FactorAnnals of Internal Medicine, 1985
- Petrosal sinus sampling for Cushing syndrome: anatomical and technical considerations. Work in progress.Radiology, 1984